Neurogene annual operating margin
2018
2024
Neurogene Operating Margin Growth & History (NGNE)
Neurogene's operating margin was −8,930.27% for fiscal 2024.
View full Neurogene company overviewNeurogene annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −8,930.27% | −8799.77 pp |
| 2018 | 2018-12-31 | −130.50% | — |
Neurogene quarterly operating margin
Q2.18
Q2.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-06-30 | −2,176.65% | — |
| Q2 2018 | 2018-06-30 | 10.76% | — |
Neurogene operating margin trends
Across the available reported history, Neurogene's operating margin decreased from −130.50% to −8,930.27%, a change of −8799.77 percentage points. The latest reported quarter, Q2 2024, shows −2,176.65%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Neurogene filings at SEC.gov ↗